Sandra Suarez
Overview
Explore the profile of Sandra Suarez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
206
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ansado J, Eynard B, Mirofle N, Mennetrey C, Banchereau J, Sablon M, et al.
Appl Neuropsychol Adult
. 2024 Feb;
:1-19.
PMID: 38354094
We present adult normalized data for MindPulse (MP), a new tool evaluating attentional and executive functioning (AEF) in decision-making. We recruited 722 neurotypical participants (18-80 years), with 149 retested. The...
2.
Suarez S, Eynard B, Granon S
Front Neurosci
. 2021 Aug;
15:650219.
PMID: 34349614
Traditionally, neuropsychological testing has assessed processing speed and precision, closely related to the ability to perform high-order cognitive tasks. An individual making a decision under time pressure must constantly rebalance...
3.
Wu F, Shah H, Li M, Duan P, Zhao P, Suarez S, et al.
AAPS J
. 2021 Feb;
23(2):31.
PMID: 33619657
Physiologically based pharmacokinetic (PBPK) absorption modeling and simulation is increasingly used as a tool in drug product development, not only in support of clinical pharmacology applications (e.g., drug-drug interaction, dose...
4.
Bretz C, Savage S, Capozzi M, Suarez S, Penn J
Sci Rep
. 2015 Nov;
5:14963.
PMID: 26527057
The objective of this study was to determine the role of individual NFAT isoforms in TNFα-induced retinal leukostasis. To this end, human retinal microvascular endothelial cells (HRMEC) transfected with siRNA...
5.
Suarez S, McCollum G, Jayagopal A, Penn J
J Biol Chem
. 2015 Oct;
290(47):28311-28320.
PMID: 26438826
Diabetic retinopathy (DR) is a leading cause of blindness worldwide, and its prevalence is growing. Current therapies for DR address only the later stages of the disease, are invasive, and...
6.
Perez D, Suarez M, Suarez S, Morano L
Rev Chilena Infectol
. 2015 Oct;
32(4):486.
PMID: 26436802
No abstract available.
7.
Gahlaut N, Suarez S, Uddin M, Gordon A, Evans S, Jayagopal A
Eur J Pharm Biopharm
. 2015 May;
95(Pt B):323-30.
PMID: 26022642
Retinal vascular diseases, including diabetic retinopathy, neovascular age related macular degeneration, and retinal vein occlusion, are leading causes of blindness in the Western world. These diseases share several common disease...
8.
Hochhaus G, Horhota S, Hendeles L, Suarez S, Rebello J
AAPS J
. 2015 Mar;
17(3):769-75.
PMID: 25762449
The presentations at the Orlando Inhalation Conference on pharmacokinetic (PK) studies indicated that PK is the most sensitive methodology for detecting formulation differences of oral inhaled drug products (OIDPs) that...
9.
Suarez S, McCollum G, Bretz C, Yang R, Capozzi M, Penn J
Invest Ophthalmol Vis Sci
. 2014 Nov;
55(12):8232-40.
PMID: 25406289
Purpose: Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability contributes to diabetic macular edema (DME), a serious vision-threatening condition. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) antagonist/reverse agonist, GSK0660, inhibits VEGF-induced human...
10.
Barnett J, Suarez S, McCollum G, Penn J
Invest Ophthalmol Vis Sci
. 2014 Aug;
55(10):6490-8.
PMID: 25159209
Purpose: We investigated endoglin expression in hypoxic microvascular endothelial cells and retinal endoglin expression in rats that develop experimental oxygen-induced retinopathy (OIR). We also tested neutralizing antibodies (Abs) against endoglin...